吉格列汀(rINN)以前被鉴定为LC15-0444,是新型二肽基肽酶-4(DPP-4)抑制剂类药物的口服抗高血糖剂(抗糖尿病药物)。众所周知,DPP-4抑制剂的降糖作用主要由GLP-1和胃抑制多肽(GIP)内分泌激素介导,而胃抑制多肽(GIP)内分泌激素被DPP-4失活。
-
默认
常备现货
-
纯度
- 请选择
- 99+%
- 99%
- 98+%
- 98%
- 97+%
- 97%
- 96+%
- 96%
- 95+%
- 95%
- 93%
- 90+%
- 90%
规格
- 请选择
- 1mg
- 2mg
- 5mg
- 10mg
- 25mg
- 50mg
- 100mg
- 250mg
- 1g
- 5g
- 10g
- 25g
- 100g
- 500g
- 1000g
- 1kg
清空选项
-
tert-Butyl 3-oxo-4-(2,2,2-trifluoroacetyl)piperidine-1-carboxylate
-
BD241608647863-25-095%
-
¥3869.001g常备现货
-
tert-Butyl 3,3-difluoropiperidine-1-carboxylate
-
BD564396911634-75-898%
-
¥379.001g常备现货
-
2,4-Bis(trifluoromethyl)-5,6,7,8-tetrahydropyrido-[3,4-d]pyrimidine hydrochloride
-
BD316091911636-86-798+%
-
¥14725.001g
-
7-Boc-2,4-bis(trifluoromethyl)-5,6,7,8-tetrahydropyrido[3,4-d]pyrimidine
-
BD316092911636-87-898+%
-
¥12148.001g